Some in vitro HNSCC cell line work suggests that inhibiting miR-21 can sensitize tumor cells to cisplatin or radiotherapy by upregulating PDCD4 and PTEN [72]. The gene discussed is PDCD4; the disease is head and neck squamous cell carcinoma.